{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T01:56:13Z","timestamp":1788832573581,"version":"build-2803163510"},"reference-count":47,"publisher":"American Association for Cancer Research (AACR)","issue":"15","funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["ZIA SC 010378"],"award-info":[{"award-number":["ZIA SC 010378"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["ZIA BC 010983"],"award-info":[{"award-number":["ZIA BC 010983"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008884","name":"Edward P. Evans Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008884","id-type":"DOI","asserted-by":"publisher"}]},{"name":"NCI Experimental Therapeutics (NExT) Program"}],"content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,8,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title\/>\n                    <jats:p>DNA methyltransferase inhibitors (DNMTi), most commonly cytidine analogs, are compounds that decrease 5\u2032-cytosine methylation. DNMTi are used clinically based on the hypothesis that cytosine demethylation will lead to re-expression of tumor suppressor genes. 5-Aza-4\u2032-thio-2\u2032-deoxycytidine (Aza-TdCyd or ATC) is a recently described thiol-substituted DNMTi that has been shown to have anti-tumor activity in solid tumor models. In this study, we investigated the therapeutic potential of ATC in a murine transplantation model of myelodysplastic syndrome. ATC treatment led to the transformation of transplanted wild-type bone marrow nucleated cells into lymphoid leukemia, and healthy mice treated with ATC also developed lymphoid leukemia. Whole-exome sequencing revealed 1,000 acquired mutations, almost all of which were C&amp;gt;G transversions in a specific 5\u2032-NCG-3\u2032 context. These mutations involved dozens of genes involved in human lymphoid leukemia, such as Notch1, Pten, Pax5, Trp53, and Nf1. Human cells treated in vitro with ATC showed 1,000 acquired C&amp;gt;G transversions in a similar context. Deletion of Dck, the rate-limiting enzyme for the cytidine salvage pathway, eliminated C&amp;gt;G transversions. Taken together, these findings demonstrate a highly penetrant mutagenic and leukemogenic phenotype associated with ATC.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Significance:<\/jats:title>\n                    <jats:p>Treatment with a DNA methyltransferase inhibitor generates a distinct mutation signature and triggers leukemic transformation, which has important implications for the research and clinical applications of these inhibitors.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1158\/0008-5472.can-23-2785","type":"journal-article","created":{"date-parts":[[2024,6,4]],"date-time":"2024-06-04T13:56:32Z","timestamp":1717509392000},"page":"2518-2532","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["The DNA Methyltransferase Inhibitor 5-Aza-4\u2032-thio-2\u2032-Deoxycytidine Induces C&amp;gt;G Transversions and Acute Lymphoid Leukemia Development"],"prefix":"10.1158","volume":"84","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7805-359X","authenticated-orcid":false,"given":"Ryan M.","family":"Bertoli","sequence":"first","affiliation":[{"name":"Genetics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland. 1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7372-2149","authenticated-orcid":false,"given":"Yang Jo","family":"Chung","sequence":"additional","affiliation":[{"name":"Genetics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland. 1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4676-7034","authenticated-orcid":false,"given":"Michael J.","family":"Difilippantonio","sequence":"additional","affiliation":[{"name":"Division of Cancer Treatment and Diagnosis, National Cancer Institute, National Institutes of Health, Bethesda, Maryland. 2"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-7742-1865","authenticated-orcid":false,"given":"Anthony","family":"Wokasch","sequence":"additional","affiliation":[{"name":"Genetics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland. 1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4722-8734","authenticated-orcid":false,"given":"Madison R.B.","family":"Marasco","sequence":"additional","affiliation":[{"name":"Genetics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland. 1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0885-0029","authenticated-orcid":false,"given":"Haley","family":"Klimaszewski","sequence":"additional","affiliation":[{"name":"Genetics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland. 1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0429-2189","authenticated-orcid":false,"given":"Susannah","family":"Gammell","sequence":"additional","affiliation":[{"name":"Genetics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland. 1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6620-9232","authenticated-orcid":false,"given":"Yuelin J.","family":"Zhu","sequence":"additional","affiliation":[{"name":"Genetics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland. 1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8235-4686","authenticated-orcid":false,"given":"Robert L.","family":"Walker","sequence":"additional","affiliation":[{"name":"Genetics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland. 1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9808-991X","authenticated-orcid":false,"given":"Dengchao","family":"Cao","sequence":"additional","affiliation":[{"name":"Genetics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland. 1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7800-5512","authenticated-orcid":false,"given":"Ajay","family":"Khanna","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Oncology, Washington University School of Medicine, Missouri. 4"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7753-1091","authenticated-orcid":false,"given":"Matthew J.","family":"Walter","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Oncology, Washington University School of Medicine, Missouri. 4"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4463-1790","authenticated-orcid":false,"given":"James H.","family":"Doroshow","sequence":"additional","affiliation":[{"name":"Division of Cancer Treatment and Diagnosis, National Cancer Institute, National Institutes of Health, Bethesda, Maryland. 2"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0963-1768","authenticated-orcid":false,"given":"Paul S.","family":"Meltzer","sequence":"additional","affiliation":[{"name":"Genetics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland. 1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5686-9969","authenticated-orcid":false,"given":"Peter D.","family":"Aplan","sequence":"additional","affiliation":[{"name":"Genetics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland. 1"},{"name":"Myeloid Malignancies Program, National Institutes of Health, Bethesda, Maryland. 3"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2024,6,4]]},"reference":[{"key":"2026042014534695100_bib1","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1056\/NEJMra1904794","article-title":"Myelodysplastic syndromes","volume":"383","author":"Cazzola","year":"2020","journal-title":"N Engl J Med"},{"key":"2026042014534695100_bib2","doi-asserted-by":"crossref","first-page":"4841","DOI":"10.1182\/blood-2007-08-078139","article-title":"Myelodysplastic syndromes","volume":"111","author":"Nimer","year":"2008","journal-title":"Blood"},{"key":"2026042014534695100_bib3","doi-asserted-by":"crossref","first-page":"4017","DOI":"10.2217\/fon-2022-0334","article-title":"Clinical impact of transformation to acute myeloid leukemia in patients with higher-risk myelodysplastic syndromes","volume":"18","author":"Kota","year":"2022","journal-title":"Future Oncol"},{"key":"2026042014534695100_bib4","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/s41408-021-00425-3","article-title":"Acute myeloid leukemia: current progress and future directions","volume":"11","author":"Kantarjian","year":"2021","journal-title":"Blood Cancer J"},{"key":"2026042014534695100_bib5","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/nrc.2016.112","article-title":"The genetics of myelodysplastic syndrome: from clonal haematopoiesis to secondary leukaemia","volume":"17","author":"Sperling","year":"2017","journal-title":"Nat Rev Cancer"},{"key":"2026042014534695100_bib6","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1038\/s41588-022-01159-z","article-title":"The genomic landscape of pediatric acute lymphoblastic leukemia","volume":"54","author":"Brady","year":"2022","journal-title":"Nat Genet"},{"key":"2026042014534695100_bib7","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1056\/NEJMoa1516192","article-title":"Genomic classification and prognosis in acute myeloid leukemia","volume":"374","author":"Papaemmanuil","year":"2016","journal-title":"N Engl J Med"},{"key":"2026042014534695100_bib8","doi-asserted-by":"crossref","first-page":"5427","DOI":"10.1038\/sj.onc.1205600","article-title":"CpG island hypermethylation and tumor suppressor genes: a booming present, a brighter future","volume":"21","author":"Esteller","year":"2002","journal-title":"Oncogene"},{"key":"2026042014534695100_bib9","doi-asserted-by":"crossref","first-page":"3109","DOI":"10.1182\/blood-2009-04-214957","article-title":"Preclinical characterization of the selective JAK1\/2 inhibitor INCB018424: therapeutic implications for the treatment of myeloproliferative neoplasms","volume":"115","author":"Quint\u00e1s-Cardama","year":"2010","journal-title":"Blood"},{"key":"2026042014534695100_bib10","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1038\/s43018-021-00271-z","article-title":"The next generation of DNMT inhibitors","volume":"2","author":"Mehdipour","year":"2021","journal-title":"Nat Cancer"},{"key":"2026042014534695100_bib11","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s00280-014-2503-z","article-title":"Novel DNA methyltransferase-1 (DNMT1) depleting anticancer nucleosides, 4\u2032-thio-2\u2032-deoxycytidine and 5-aza-4\u2032-thio-2\u2032-deoxycytidine","volume":"74","author":"Thottassery","year":"2014","journal-title":"Cancer Chemother Pharmacol"},{"key":"2026042014534695100_bib12","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1124\/jpet.121.000758","article-title":"5-Aza-4\u2032-thio-2\u2032-deoxycytidine, a new orally bioavailable nontoxic \u201cBest-in-Class\u201d: DNA methyltransferase 1-depleting agent in clinical development","volume":"379","author":"Parker","year":"2021","journal-title":"J Pharmacol Exp Ther"},{"key":"2026042014534695100_bib13","doi-asserted-by":"crossref","first-page":"14088","DOI":"10.1073\/pnas.0804507105","article-title":"Transplantation of a myelodysplastic syndrome by a long-term repopulating hematopoietic cell","volume":"105","author":"Chung","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2026042014534695100_bib14","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1182\/blood-2004-12-4794","article-title":"NUP98-HOXD13 transgenic mice develop a highly penetrant, severe myelodysplastic syndrome that progresses to acute leukemia","volume":"106","author":"Lin","year":"2005","journal-title":"Blood"},{"key":"2026042014534695100_bib15","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1182\/blood.V100.1.246","article-title":"Bethesda proposals for classification of lymphoid neoplasms in mice","volume":"100","author":"Morse","year":"2002","journal-title":"Blood"},{"key":"2026042014534695100_bib16","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/sj.leu.2401997","article-title":"Development and characterization of T cell leukemia cell lines established from SCL\/LMO1 double transgenic mice","volume":"15","author":"Chervinsky","year":"2001","journal-title":"Leukemia"},{"key":"2026042014534695100_bib17","doi-asserted-by":"crossref","first-page":"e131434","DOI":"10.1172\/jci.insight.131434","article-title":"A unique mutator phenotype reveals complementary oncogenic lesions leading to acute leukemia","volume":"4","author":"Yin","year":"2019","journal-title":"JCI Insight"},{"key":"2026042014534695100_bib18","doi-asserted-by":"crossref","first-page":"5033","DOI":"10.1158\/0008-5472.CAN-21-1027","article-title":"Mutant Idh2 cooperates with a NUP98-HOXD13 fusion to induce early immature thymocyte precursor ALL","volume":"81","author":"Goldberg","year":"2021","journal-title":"Cancer Res"},{"key":"2026042014534695100_bib19","doi-asserted-by":"crossref","first-page":"e22430","DOI":"10.1096\/fj.202200061RR","article-title":"Mcm2 hypomorph leads to acute leukemia or hematopoietic stem cell failure, dependent on genetic context","volume":"36","author":"Matsukawa","year":"2022","journal-title":"FASEB J"},{"key":"2026042014534695100_bib20","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1093\/bioinformatics\/btp324","article-title":"Fast and accurate short read alignment with Burrows-Wheeler transform","volume":"25","author":"Li","year":"2009","journal-title":"Bioinformatics"},{"key":"2026042014534695100_bib21","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1101\/gr.107524.110","article-title":"The genome analysis toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data","volume":"20","author":"McKenna","year":"2010","journal-title":"Genome Res"},{"key":"2026042014534695100_bib22","doi-asserted-by":"crossref","first-page":"100179","DOI":"10.1016\/j.xgen.2022.100179","article-title":"Uncovering novel mutational signatures by de novo extraction with SigProfilerExtractor","volume":"2","author":"Islam","year":"2022","journal-title":"Cell Genom"},{"key":"2026042014534695100_bib23","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s12859-021-04556-z","article-title":"ChromoMap: an R package for interactive visualization of multi-omics data and annotation of chromosomes","volume":"23","author":"Anand","year":"2022","journal-title":"BMC Bioinformatics"},{"key":"2026042014534695100_bib24","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1038\/leu.2016.282","article-title":"Dynamic changes in the clonal structure of MDS and AML in response to epigenetic therapy","volume":"31","author":"Uy","year":"2017","journal-title":"Leukemia"},{"key":"2026042014534695100_bib25","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1056\/NEJMoa1605949","article-title":"TP53 and decitabine in acute myeloid leukemia and myelodysplastic syndromes","volume":"375","author":"Welch","year":"2016","journal-title":"N Engl J Med"},{"key":"2026042014534695100_bib26","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1056\/NEJMoa1106968","article-title":"Clonal architecture of secondary acute myeloid leukemia","volume":"366","author":"Walter","year":"2012","journal-title":"N Engl J Med"},{"key":"2026042014534695100_bib27","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/nature12477","article-title":"Signatures of mutational processes in human cancer","volume":"500","author":"Alexandrov","year":"2013","journal-title":"Nature"},{"key":"2026042014534695100_bib28","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/s41586-020-1943-3","article-title":"The repertoire of mutational signatures in human cancer","volume":"578","author":"Alexandrov","year":"2020","journal-title":"Nature"},{"key":"2026042014534695100_bib29","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1038\/s41375-018-0200-3","article-title":"A non-myeloablative conditioning approach for long-term engraftment of human and mouse hematopoietic stem cells","volume":"32","author":"Du","year":"2018","journal-title":"Leukemia"},{"key":"2026042014534695100_bib30","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.3389\/fphar.2020.01044","article-title":"Targeting the microenvironment in MDS: the final frontier","volume":"11","author":"Teodorescu","year":"2020","journal-title":"Front Pharmacol"},{"key":"2026042014534695100_bib31","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1182\/blood-2015-06-653113","article-title":"Targeting of the bone marrow microenvironment improves outcome in a Murine model of myelodysplastic syndrome","volume":"127","author":"Balderman","year":"2016","journal-title":"Blood"},{"key":"2026042014534695100_bib32","doi-asserted-by":"crossref","first-page":"D941","DOI":"10.1093\/nar\/gky1015","article-title":"COSMIC: the catalogue of somatic mutations in cancer","volume":"47","author":"Tate","year":"2019","journal-title":"Nucleic Acids Res"},{"key":"2026042014534695100_bib33","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1093\/carcin\/24.1.31","article-title":"Assessment of mismatch repair function in leukaemic cell lines and blasts from children with acute lymphoblastic leukaemia","volume":"24","author":"Matheson","year":"2003","journal-title":"Carcinogenesis"},{"key":"2026042014534695100_bib34","doi-asserted-by":"crossref","first-page":"e98962","DOI":"10.1172\/jci.insight.98962","article-title":"Subclones dominate at MDS progression following allogeneic hematopoietic cell transplant","volume":"3","author":"Jacoby","year":"2018","journal-title":"JCI Insight"},{"key":"2026042014534695100_bib35","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/s41568-023-00557-7","article-title":"Nucleotide metabolism: a pan-cancer metabolic dependency","volume":"23","author":"Mullen","year":"2023","journal-title":"Nat Rev Cancer"},{"key":"2026042014534695100_bib36","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/nature13992","article-title":"A comparative encyclopedia of DNA elements in the mouse genome","volume":"515","author":"Yue","year":"2014","journal-title":"Nature"},{"key":"2026042014534695100_bib37","doi-asserted-by":"crossref","first-page":"5551","DOI":"10.1073\/pnas.0913900107","article-title":"Requirement for deoxycytidine kinase in T and B lymphocyte development","volume":"107","author":"Toy","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2026042014534695100_bib38","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1101\/gr.230219.117","article-title":"In-depth characterization of the cisplatin mutational signature in human cell lines and in esophageal and liver tumors","volume":"28","author":"Boot","year":"2018","journal-title":"Genome Res"},{"key":"2026042014534695100_bib39","doi-asserted-by":"crossref","first-page":"197ra102","DOI":"10.1126\/scitranslmed.3006200","article-title":"Mutational signature of aristolochic acid exposure as revealed by whole-exome sequencing","volume":"5","author":"Hoang","year":"2013","journal-title":"Sci Transl Med"},{"key":"2026042014534695100_bib40","first-page":"763","article-title":"The genome as a record of environmental exposure","volume":"30","author":"Nik-Zainal","year":"2015","journal-title":"Mutagenesis"},{"key":"2026042014534695100_bib41","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1073\/pnas.70.3.782","article-title":"An improved bacterial test system for the detection and classification of mutagens and carcinogens","volume":"70","author":"Ames","year":"1973","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2026042014534695100_bib42","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1073\/pnas.61.4.1306","article-title":"Mammalian cell genetics. II. chemical induction of specific locus mutations in Chinese hamster cells in vitro","volume":"61","author":"Chu","year":"1968","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2026042014534695100_bib43","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/0027-5107(72)90066-8","article-title":"A mutational assay system using the thymidine kinase locus in mouse lymphoma cells","volume":"16","author":"Clive","year":"1972","journal-title":"Mutat Res"},{"key":"2026042014534695100_bib44","doi-asserted-by":"crossref","first-page":"7971","DOI":"10.1073\/pnas.86.20.7971","article-title":"Efficient rescue of integrated shuttle vectors from transgenic mice: a model for studying mutations in vivo","volume":"86","author":"Gossen","year":"1989","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2026042014534695100_bib45","doi-asserted-by":"crossref","first-page":"e003392","DOI":"10.1136\/jitc-2021-003392","article-title":"Pembrolizumab and decitabine for refractory or relapsed acute myeloid leukemia","volume":"10","author":"Goswami","year":"2022","journal-title":"J Immunother Cancer"},{"key":"2026042014534695100_bib46","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.18632\/oncotarget.1542","article-title":"Alterations of immune response of non-small cell lung cancer with azacytidine","volume":"4","author":"Wrangle","year":"2013","journal-title":"Oncotarget"},{"key":"2026042014534695100_bib47","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/j.cell.2015.07.011","article-title":"Inhibiting DNA methylation causes an interferon response in cancer via dsRNA including endogenous retroviruses","volume":"162","author":"Chiappinelli","year":"2015","journal-title":"Cell"}],"container-title":["Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/doi\/10.1158\/0008-5472.CAN-23-2785\/3459877\/can-23-2785.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/84\/15\/2518\/3479400\/can-23-2785.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/84\/15\/2518\/3479400\/can-23-2785.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T18:54:01Z","timestamp":1776711241000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerres\/article\/84\/15\/2518\/746548\/The-DNA-Methyltransferase-Inhibitor-5-Aza-4-thio-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,4]]},"references-count":47,"journal-issue":{"issue":"15","published-online":{"date-parts":[[2024,6,4]]},"published-print":{"date-parts":[[2024,8,1]]}},"URL":"https:\/\/doi.org\/10.1158\/0008-5472.can-23-2785","relation":{"is-supplemented-by":[{"id-type":"doi","id":"10.1158\/0008-5472.26423917","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.26423917.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.32702895","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.32702898","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.26423920","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.26423920.v1","asserted-by":"object"}],"has-preprint":[{"id-type":"doi","id":"10.1158\/0008-5472.c.7380253.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.c.7380253","asserted-by":"object"}]},"ISSN":["0008-5472","1538-7445"],"issn-type":[{"value":"0008-5472","type":"print"},{"value":"1538-7445","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,4]]}}}